High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
IJMS | Free Full-Text | Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
Biology of secondary leukemia
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018
Outcome of patients with either de novo or secondary AML after alloSCT... | Download Scientific Diagram
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
What is AML? | MDS Foundation
Acute Myeloid Leukemia | Oncohema Key
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal
A) Incidence of De Novo, Secondary, and Therapy-Related Acute Myeloid... | Download Scientific Diagram
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology
Mutational variation in de-novo and secondary acute myeloid Leukemia.... | Download Scientific Diagram
JCM | Free Full-Text | Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal
Frontiers | Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
